Stock Expert AI

Content generated by AI editorial engine. Editorially supervised by Sedat ANAK.

Allegion plc
ALLE - NYSE - $134.37 (as of ) ▼ -1.78%
-
Earnings Thu 23 Jul
Note: this preview was published before the 2026-07-23 earnings report. Results have since been released — verify against the latest filings.

Allegion plc (ALLE) Q2 FY26 earnings preview — archived, published May 9, 2026

The median of 1 price targets is $173[FMP target], stock is $134, +28.4% vs the analyst consensus median. Q1 FY26 EPS $1.80 vs $1.88 estimate: miss (-4.3%)[FMP earnings]. Stock move on D+1: -0.4%.

↓ summary below
Quick Take - in 40 seconds ·
B+
Council 4/6 - Historical V1 score 40

B+ — FMP rating [FMP ratings]. Form 4: unavailable[FMP Form 4].

Quick Answer

Allegion plc (ALLE) Q2 consensus: revenue $1.1B[FMP est], EPS $2.22[FMP est]. 0 consecutive quarters of beat[FMP earnings].

$2.22 EPS Estimate Last year $2.04 - +9% YoY
0 Beat Streak Expectations beaten consecutively for the last 0 quarters

Q1 FY26 EPS $1.80 vs $1.88 estimate: miss (-4.3%)[FMP]. Stock move on D+1: -0.4%[FMP D+1].

Watchlist

4 metrics stand out this quarter.

6% Expectation / Guide

Revenue Growth Outlook

revenue_growth_outlook

Allegion is raising its reported revenue outlook to 6% to 8% to include the DCI acquisition, while affirming its organic revenue growth outlook of 2% to 4% and adjusted earnings per share outlook of $8.70 to $8.90.

"we are raising our reported revenue outlook to 6% to 8% to include the DCI acquisition, and we are affirming our outlook for organic revenue growth of 2% to 4% and adjusted earnings per share of $8.70 to $8.90."

- John Stone, President and Chief Executive Officer - Q1 FY26 Earnings Call - April 28, 2026
1% Investor Focus

Inflation Impact Offset

inflation_impact_offset

We anticipate an incremental headwind of approximately 1% of COGS from tariffs and other inflation. We expect to offset this on a dollar basis through a combination of price and cost actions. However, given current volatility, we are not updating our organic growth assumptions to include any incremental price at this time, similar to our approach in the first quarter of 2025. Most importantly, we expect this to be neutral to 2026 adjusted operating income dollars and earnings per share.

"Based on current conditions, we anticipate an incremental headwind of approximately 1% of COGS from tariffs and other inflation. We expect to offset this on a dollar basis through a combination of price and cost actions. However, given current volatility, we are not updating our organic growth assumptions to include any incremental price at this time, similar to our approach in the first quarter of 2025. Most importantly, we expect this to be neutral to 2026 adjusted operating income dollars and earnings per share."

- John Stone, President and Chief Executive Officer - Q1 FY26 Earnings Call - April 28, 2026
- Investor Focus

Americas Nonres Growth

americas_nonres_growth

Our nonresidential business increased mid-single digits organically, driven by price realization, as residential markets remain soft.

"Our nonresidential business increased mid-single digits organically, driven by price realization."

- Michael Wagnes, Senior Vice President and Chief Financial Officer - Q1 FY26 Earnings Call - April 28, 2026
- Investor Focus

International Erp Impact

international_erp_impact

Organic revenue declines were the result of volume weaknesses in our mechanical business, primarily related to the ERP disruptions John discussed earlier.

"Organic revenue declines were the result of volume weaknesses in our mechanical business, primarily related to the ERP disruptions John discussed earlier."

- Michael Wagnes, Senior Vice President and Chief Financial Officer - Q1 FY26 Earnings Call - April 28, 2026

Stock Expert AI - Methodology

Do our scoring pillars, 6 perspectives, and Munger lens point in the same direction?

Council Score 4 / 6 Bullish

6 investor frameworks. 4 bullish (Ray Dalio, Klarman, Buffett, Munger), 1 bearish (Ken Griffin), 1 neutral (Jim Simons).

How is it calculated? ->
Ray Dalio macro - target upside +28.4%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 38
Klarman value - target upside +28.4%
Buffett quality - ROE score 5/5
Munger valuation - target upside +28.4%
Munger's Mindset character & balance sheet lens
Undervalued

Quality business, discounted price.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyStrong
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
38.2 RSI 38.2 weak momentum, 50d below
MACD
-7.10 price below 50d - resistance dominant
50d MA
$145 stock 7.1% below - short-term resistance
200d MA
$162 stock 17.0% below - long-term pressure
Volume (10d)
-30% decrease - low participation
Resistance
$173
Analyst median target - upgrade trigger if broken
Current
$134
Pre-earnings position
Support
$138
Invalidation - close below this is a technical breakdown
Pattern
Range
$138-$173 band - earnings breakout/breakdown trigger

Past Performance

4 quarters shown.

BEAT
Q2 FY25
$2.04 vs $1.99 est · Next-day price move: +1.1%
BEAT
Q3 FY25
$2.30 vs $2.21 est · Next-day price move: -2.3%
MISS
Q4 FY25
$1.94 vs $2.01 est · Next-day price move: -0.0%
MISS
Q1 FY26
$1.80 vs $1.88 est · Next-day price move: -0.4%

Q1 FY26 (April 28, 2026) EPS $1.80 vs $1.88 estimate: miss (-4.3%)[FMP]. Stock move on D+1: -0.4%[FMP D+1].

Three scenarios: what could happen?

EPS < $2.15 (no guidance)

Q1 FY26 EPS $1.80 vs $1.88 estimate: miss (-4.3%)[FMP]. Stock move on D+1: -0.4%[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $21.0M[FMP cashflow]. Q1 op margin 18.9%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q2 EPS > $2.22 + CapEx discipline
Threshold: EPS > $2.22[FMP est].
Target: Break above median target $173[FMP target]; high target $180[FMP] upper bound.
Scenario B - In-Line
EPS approx $2.22 + CapEx < $21.0M
Threshold: EPS approx $2.22[FMP est], Q4 CapEx < $21.0M[FMP].
Target: Consolidation in the band between current $134[FMP] and median $173[FMP].
Scenario C - Miss
EPS < $2.15 or CapEx >= $21.0M
Threshold: EPS < $2.15[FMP estx0.97].
Current price $134 — below SMA200 $162 [FMP].

Market Outlook

What do analysts say? 1 price targets · 13 ratings

Wall Street Consensus
$173
12-month median target price (+28.4% gap to the analyst consensus median)
5
BUY
8
HOLD
0
SELL
Risk Management
$138
Invalidation level - critical support threshold
$145 - 50-day MA (below, -7.1%)
$162 - 200-day MA (below, -17.0%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - ALLE Q2 FY26
B+

You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Thursday evening. The framework is ready on this page: Q2 EPS threshold $2.22[FMP], CapEx threshold "below $21.0M". Two anchors, three scenarios.

Comparison Stock Expert AI is free today — no credit card.

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI is free today — no credit card. Council 7-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Jul 23, 2026EARNINGSQ2 FY26 results (after market close) + earnings call
Jul 24, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Aug 9, 2026 – Aug 14, 2026FILING10-Q due within 40–45 days of quarter end (by Aug 9, 2026 – Aug 14, 2026); the exact deadline depends on filer status
~Oct 23, 2026EARNINGSQ3 FY26 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the ALLE Q2 FY26 earnings preview cover?

This Allegion plc (ALLE) Q2 FY26 earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in ALLE Q2 FY26 earnings?

Allegion plc (ALLE): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.

Where do the numbers on this page come from?

Allegion plc (ALLE): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.

Is this a buy or sell recommendation?

Allegion plc (ALLE): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.

More earnings, decoded